Hemostatic Instruments Market Size, Growth, Trends | Report 2022-2030
The global hemostatic instruments market is growing immensely owing to several growth factors such as the rising number of surgical procedures, surging cases of sports-related injuries, and increasing incidence of chronic diseases such as cardiovascular, orthopedic, and trauma across the globe. The increase in number of surgical procedures may lead to several complications including bleeding, which is anticipated to surge the demand for hemostatic instruments in the forecast period. Additionally, increasing access to health care services, technological advancements, and the entry of new manufacturers are other factors expected to augment the hemostatic devices market.
Hemostasis and tissue sealing agents are used to prevent hemorrhage. During surgery, it is very essential to stop the excessive bleeding in patient to avoid further organ damage or death by excess blood loss. This has created the need for hemostasis instruments in the forecast period. The hemostatic instruments market is segmented on the basis of type and application. On the basis of type, the market is segmented into mechanical, flowable, and active. Mechanical type is anticipated to hold highest market share in 2021. Based on application, the market is segmented into cardiovascular surgery, general surgery, orthopedic surgery, gynecologic surgery and others.
The North America is expected to dominate the market in 2021 owing to advanced treatment facilities and increasing focus on effective blood management among patients during surgeries is expected to foster regional growth.
Some of the major companies operating in the market are Johnson & Johnson, Medtronic, CryoLife, Inc., Becton, Dickinson and Company, Pfizer, Baxter, Stryker, CryoLife, Inc., B. Braun Melsungen AG, and Smith & Nephew. These market players are focusing on several market strategies such as product launches, mergers & acquisitions, partnerships, collaboration, and others to strengthen their market position. For instance, in May 2022, BD announced the launch of scientific office in Egypt to enhance patient safety and healthcare worker safety in the Middle East & North America (MENA) region.
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Hemostatic Instruments Market
5.1. COVID-19 Landscape: Hemostatic Instruments Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Hemostatic Instruments Market, By Type
8.1. Hemostatic Instruments Market, by Type, 2022-2030
8.1.1. Active
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Mechanical
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Flowable
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Hemostatic Instruments Market, By Application
9.1. Hemostatic Instruments Market, by Application, 2022-2030
9.1.1. Cardiovascular Surgery
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. General Surgery
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Orthopedic Surgery
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Gynecologic Surgery
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Hemostatic Instruments Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
Chapter 11. Company Profiles
11.1. Johnson & Johnson
11.1.1. Company Overview
11.1.2. Type Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Medtronic
11.2.1. Company Overview
11.2.2. Type Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. CryoLife, Inc.
11.3.1. Company Overview
11.3.2. Type Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Becton
11.4.1. Company Overview
11.4.2. Type Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Dickinson and Company
11.5.1. Company Overview
11.5.2. Type Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Pfizer
11.6.1. Company Overview
11.6.2. Type Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Baxter
11.7.1. Company Overview
11.7.2. Type Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Stryker
11.8.1. Company Overview
11.8.2. Type Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. CryoLife, Inc.
11.9.1. Company Overview
11.9.2. Type Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. B. Braun Melsungen AG
11.10.1. Company Overview
11.10.2. Type Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers